← Abivax S.A.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net Income | — | — | ($60.7m) |
($147.7m)
-143.23%
|
($176.2m)
-19.29%
|
($336.1m)
-90.70%
|
($332.2m)
+1.16%
|
|
| Net loss for the period | — | ($42.5m) | ($60.7m) | ($147.7m) | ($176.2m) | ($336.1m) | — | |
| Profit or Loss | — | — | ($60.7m) | ($147.7m) | ($176.2m) | ($336.1m) | — | |
| Amortization of intangibles and depreciation of property, plant and equipment | — | $302k | $485k | $707k | $1.1m | $1.1m | $0 | |
| Amortization Cash Flow | — | $156k | $309k | $0 | — | — | — | |
| Amortization Of Intangibles | — | $156k | $309k | $0 | — | — | $0 | |
| Depreciation | — | — | — | $708k | — | — | $708k | |
| Depreciation Amortization Depletion | — | — | $485k | $707k | $1.1m | $1.1m | $1.2m | |
| Current and deferred taxes expenses | — | — | — | $0 | $0 | $5.8m | — | |
| Deferred Income Tax | — | — | — | $0 | $0 | $5.8m | $6.1m | |
| Adjustments For Share-Based Payments | — | — | ($1.2m) | $8.2m | $20.2m | $35.4m | — | |
| Share-based compensation expenses | — | $828k | ($1.2m) | $8.2m | $20.2m | $35.4m | $53.3m | |
| Asset Impairment Charge | — | $0 | $13.6m | $0 | $0 | — | $0 | |
| Changes in working capital requirements | — | ($667k) | ($2.0m) | $21.3m | $1.4m | $3.7m | — | |
| Change In Working Capital | — | — | ($2.0m) | $21.3m | $1.4m | $3.7m | ($10.3m) | |
| Decrease / (increase) in other receivables and related accounts | — | ($2.0m) | $312k | ($14.2m) | $4.6m | $7.0m | — | |
| Change In Receivables | — | — | $312k | ($14.2m) | $4.6m | $7.0m | $5.7m | |
| Increase / (decrease) in trade payables | — | $1.1m | ($2.4m) | $31.8m | ($3.4m) | ($6.2m) | — | |
| Other | — | $0 | $0 | $160k | $245k | $300k | — | |
| Changes in deferred income and other liabilities | — | ($41k) | ($26k) | ($81k) | $1.8m | $710k | — | |
| Change In Other Current Assets | — | $168k | ($32k) | $3.7m | — | — | $3.7m | |
| Acquisitions of property, plant and equipment | — | ($47k) | ($288k) | ($265k) | ($640k) | ($142k) | — | |
| Capital Expenditure | — | — | ($323k) | ($265k) | ($643k) | ($142k) | ($152k) | |
| Acquisitions of intangible assets | — | $0 | ($35k) | $0 | ($3k) | $0 | — | |
| Net Other Investing Changes | — | — | ($8.8m) | ($10.2m) | $8.2m | ($13.6m) | ($13.6m) | |
| Proceeds From Borrowings Classified As Financing Activities | — | — | — | $125.0m | — | $175.0m | — | |
| Issuance Of Debt | — | — | $0 | $55.8m | $47.9m | $0 | $23k | |
| Long Term Debt Issuance | — | — | $0 | $55.8m | $47.9m | $0 | $23k | |
| Net Issuance Payments Of Debt | — | — | ($9.7m) | $15.2m | $37.5m | ($59.5m) | ($53.8m) | |
| Net Long Term Debt Issuance | — | — | ($9.7m) | $15.2m | $37.5m | ($59.5m) | ($53.8m) | |
| Long Term Debt Payments | — | — | ($9.7m) | ($40.6m) | ($10.5m) | ($59.5m) | ($53.8m) | |
| Repayment Of Debt | — | — | ($9.7m) | ($40.6m) | ($10.5m) | ($59.5m) | ($53.8m) | |
| Issuance Of Capital Stock | — | — | $46.4m | $353.4m | $434k | $648.1m | $648.1m | |
| Common Stock Issuance | — | — | $46.4m | $353.4m | $434k | $648.1m | $648.1m | |
| Cash Dividends Paid | — | — | $0 | $0 | $0 | $0 | $0 | |
| Net Other Financing Charges | — | — | ($437k) | ($28.1m) | ($2.0m) | ($40.6m) | ($40.6m) | |
| Increase (decrease) in cash and cash equivalents | — | $31.4m | ($33.8m) | $225.0m | ($107.7m) | $372.5m | — | |
| Beginning Cash Position | — | — | $60.7m | $26.9m | $251.9m | $144.2m | $103.6m | |
| Cash and cash equivalents at the beginning of the year | $29.3m | $60.7m | $26.9m | $251.9m | $144.2m | $516.7m | — | |
| Effect of movements in exchange rates on cash held | — | $0 | $0 | ($5.1m) | $2.4m | ($10.3m) | — | |
| Effect Of Exchange Rate Changes | — | — | $0 | ($5.1m) | $2.4m | ($10.3m) | $1.1m | |
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Interest expenses and other financial expenses | — | $3.6m | $7.0m | $24.8m | $14.2m | $45.7m | — | |
| Additional Financial Items | ||||||||
| Adjustments For Increase Decrease In Trade Account Payable | — | — | ($2.4m) | $31.8m | ($3.4m) | ($6.2m) | — | |
| General And Administrative Expense | — | — | $7.5m | $22.4m | $32.9m | $67.7m | — | |
| Goodwill | — | — | $18.4m | $18.4m | $18.4m | $18.4m | $0 | |
| Increase Decrease In Working Capital | — | — | $2.0m | ($21.3m) | ($1.4m) | ($3.7m) | ($10.3m) | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | $301k | $529k | $458k | $911k | — | |
| Proceeds From Issuing Shares | — | — | $46.2m | $353.4m | $0 | $648.1m | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | — | — | $35k | $0 | $3k | $0 | — | |
| Retirement benefit obligations | — | $117k | $143k | $109k | $74k | ($65k) | — | |
| Net gain on sale of treasury shares | — | $0 | ($108k) | ($34k) | ($16k) | $0 | — | |
| Financial income | — | $0 | ($288k) | ($3.0m) | ($11.6m) | ($23.8m) | — | |
| Effect of unwinding the discount related to advances | — | $1.9m | ($2k) | ($355k) | ($710k) | ($153k) | — | |
| Increase/(decrease) in derivatives and liabilities measured at fair value | — | ($2.4m) | ($10.8m) | ($1.2m) | $1.4m | $62.3m | — | |
| Forgiveness of conditional advances | — | — | $0 | $0 | ($4.1m) | $0 | — | |
| Changes in provisions | — | — | — | $0 | $0 | $44.7m | — | |
| Increase / (decrease) in tax and social security liabilities | — | $209k | $100k | $3.8m | ($1.5m) | $2.1m | — | |
| Advances reimbursed by / (made to) CROs | — | — | — | ($1.6m) | ($231k) | $71k | — | |
| Increase in deposits | — | — | ($142k) | ($9.4m) | ($591k) | ($14.2m) | — | |
| Decrease in deposits | — | $0 | $218k | $741k | $9.1m | $500k | — | |
| Interest received | — | $0 | $19k | $2.4m | $8.2m | $5.5m | $5.1m | |
| Capital increases | — | $69.7m | $46.2m | $353.4m | $0 | $648.1m | — | |
| Transaction costs related to capital increase | — | ($4.2m) | ($3.3m) | ($28.1m) | $446k | ($40.9m) | — | |
| Net proceeds from non-convertible bond loans | — | — | $0 | $0 | $47.9m | $0 | — | |
| Repayments of non-convertible bond loans | — | — | ($9.4m) | ($11.6m) | $0 | ($53.9m) | — | |
| Net proceeds from convertible loan notes | — | $24.9m | $0 | $55.8m | $0 | $0 | — | |
| Repayments of convertible loan notes | — | $0 | $0 | ($27.2m) | ($8.8m) | ($2.2m) | — | |
| Repayment of PGE | — | $0 | $0 | ($1.2m) | ($1.2m) | ($2.5m) | — | |
| Repayments of conditional advances | — | ($70k) | ($90k) | ($110k) | ($2.7m) | $0 | — | |
| Payments of the lease liabilities | — | ($249k) | ($301k) | ($529k) | ($458k) | ($911k) | — | |
| Net proceeds from sale of treasury shares | — | $0 | $143k | $10k | $434k | $0 | — | |
| Exercise of warrants | — | $0 | $3k | $3k | $0 | $5.8m | — | |
| Cash Flow From Continuing Financing Activities | — | — | $32.2m | $335.3m | $28.2m | $547.3m | $555.2m | |
| Cash Flow From Continuing Investing Activities | — | — | ($12.0m) | ($8.1m) | $15.8m | ($8.2m) | ($8.8m) | |
| Change In Account Payable | — | — | ($2.4m) | $31.8m | ($3.4m) | ($6.2m) | ($27.0m) | |
| Change In Income Tax Payable | — | — | $100k | $3.8m | ($1.5m) | $2.1m | $10.3m | |
| Change In Other Working Capital | — | — | ($26k) | ($81k) | $1.8m | $710k | $710k | |
| Change In Payable | — | — | ($2.3m) | $35.6m | ($4.9m) | ($4.1m) | ($27.0m) | |
| Change In Tax Payable | — | — | $100k | $3.8m | ($1.5m) | $2.1m | $10.3m | |
| Changes In Cash | — | — | ($33.8m) | $230.1m | ($110.1m) | $382.7m | $372.8m | |
| End Cash Position | — | — | $26.9m | $251.9m | $144.2m | $516.7m | $476.4m | |
| Financing Cash Flow | — | — | $32.2m |
$335.3m
+940.92%
|
$28.2m
-91.59%
|
$547.3m
+1840.32%
|
$555.2m
+1.45%
|
|
| Free Cash Flow | — | — | ($54.3m) | ($97.4m) | ($154.7m) | ($161.3m) | ($178.5m) | |
| Gain Loss On Investment Securities | — | — | ($10.9m) | ($1.2m) | $1.4m | $62.3m | $62.3m | |
| Investing Cash Flow | — | — | ($12.0m) | ($8.1m) | $15.8m | ($8.2m) | ($8.8m) | |
| Net Business Purchase And Sale | — | ($2.2m) | ($2.9m) | $0 | $0 | — | $80k | |
| Net Foreign Currency Exchange Gain Loss | — | $0 | $0 | $5.6m | — | — | $5.6m | |
| Net Intangibles Purchase And Sale | — | — | ($35k) | $0 | ($3k) | $0 | $0 | |
| Net PPE Purchase And Sale | — | — | ($288k) | ($265k) | ($640k) | ($142k) | ($152k) | |
| Operating Gains Losses | — | — | ($10.8m) | ($1.1m) | $1.5m | $62.3m | $61.2m | |
| Other Cash Adjustment Inside Changein Cash | — | — | — | $0 | $0 | $4.7m | — | |
| Other Cash Adjustment Outside Changein Cash | — | — | ($3k) | ($1k) | — | — | — | |
| Other Non Cash Items | — | — | $6.6m | $21.5m | ($2.1m) | $22.0m | — | |
| Pension And Employee Benefit Expense | — | — | $143k | $109k | $74k | ($65k) | ($67k) | |
| Proceeds From Stock Option Exercised | — | — | $3k | $0 | $0 | $5.8m | $6.3m | |
| Provisionand Write Offof Assets | — | — | — | $0 | $0 | $44.7m | $32.4m | |
| Purchase Of Business | — | ($2.2m) | ($2.9m) | $0 | $0 | — | $0 | |
| Purchase Of Intangibles | — | — | ($35k) | $0 | ($3k) | $0 | $0 | |
| Purchase Of PPE | — | — | ($288k) | ($265k) | ($640k) | ($142k) | ($152k) | |
| Stock Based Compensation | — | — | ($1.2m) | $8.2m | $20.2m | $35.4m | $53.3m | |
| Net Investment Purchase And Sale | — | ($9k) | ($470k) | ($8.6m) | — | — | $0 | |
| Purchase Of Investment | — | ($9k) | ($470k) | ($9.4m) | — | — | ($9.4m) | |
| Sale Of Investment | — | $0 | $218k | $741k | — | — | $0 | |
| Revaluation of cash equivalents measured at fair value | — | — | — | $0 | $0 | $4.7m | — | |
| Change In Cash Supplemental As Reported | — | — | ($33.8m) | $225.0m | ($107.7m) | $372.5m | — | |
| Interest Paid Classified As Financing Activities | — | ($1.9m) | $4.0m | $5.3m | $7.7m | $6.5m | — | |
| Income Taxes Paid Refund Classified As Operating Activities | — | $0 | — | $0 | $0 | $0 | — |